Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
2007
Accuracy of Three Automated Systems (MicroScan WalkAway, VITEK, and VITEK 2) for Susceptibility Testing of Pseudomonas aeruginosa against Five Broad-Spectrum Beta-Lactam Agents
2006
Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity
2007 StandoutNobel
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40
2006
Antimicrobial resistance trends and outbreak frequency in united states hospitals
2004
Nosocomial Infections Due to Multidrug‐Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options
2005
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
2008 Standout
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002
2005
Prevalence and Risk Factor Analysis of Trimethoprim‐Sulfamethoxazole– and Fluoroquinolone‐ResistantEscherichia coliInfection among Emergency Department Patients with Pyelonephritis
2008
Structure?Activity Relationships for Three Macrolide Antibiotics in Haemophilus influenzae
2004
Emerging antibiotic resistance in urinary tract pathogens
2003
Similarity between Human and ChickenEscherichia coliIsolates in Relation to Ciprofloxacin Resistance Status
2006
Molecular mechanisms of antibiotic resistance
2014 Standout
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Lateral gene transfer and the nature of bacterial innovation
2000 StandoutNature
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units
2006
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli
2006
Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela: comparison of data from 1997 and 1998 using the Etest method
1999
Antibiotics in the aquatic environment – A review – Part I
2009 Standout
Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multidrug-resistant Acinetobacter baumannii isolated from nosocomial infections
2007
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Integrons as tools for epidemiological studies
2004
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
The Integron/Gene Cassette System: An Active Player in Bacterial Adaptation
2009
Infection Control — A Problem for Patient Safety
2003 Standout
Changes in the Epidemiology of Methicillin-Resistant Staphylococcus aureus in Intensive Care Units in US Hospitals, 1992-2003
2006
A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor
2010
Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008
2010
Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial
2007
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Emergence and management of drug-resistant enterococcal infections
2008
Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme
2008
Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia: comparison of data from 1997 and 1998 using the Etest method
1999
Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centers: 6-year report of the MYSTIC Surveillance Study (1997–2002)
2005
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity
2007
Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study
2005
Integrons and β-lactamases—a novel perspective on resistance
2004
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
2005
Resistance surveillance studies: a multifaceted problem—the fluoroquinolone example
2012
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
Physiological heterogeneity in biofilms
2008 Standout
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
2005
Genomic and Functional Characterization of Enterococcus faecalis Isolates Recovered From the International Space Station and Their Potential for Pathogenicity
2021 StandoutNobel
Evidence of Extensive Interspecies Transfer of Integron‐Mediated Antimicrobial Resistance Genes among Multidrug‐Resistant Enterobacteriaceae in a Clinical Setting
2002
Occurrence of antibiotic resistance inEscherichia colifrom surface waters and fecal pollution sources near Hamilton, Ontario
2005
Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing Strains
2005
Pharmacodynamic assessment of the activity of high-dose (750 mg) levofloxacin, ciprofloxacin, and gatifloxacin against clinical strains of Pseudomonas aeruginosa
2005
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Antibiotic resistance in the environment
2021 Standout
Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003
2008
Societal Costs Versus Savings from Wild-Card Patent Extension Legislation to Spur Critically Needed Antibiotic Development
2007
Call of the wild: antibiotic resistance genes in natural environments
2010 Standout
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY
2007
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Levofloxacin for Treatment of Ventilator-Associated Pneumonia: A Subgroup Analysis from a Randomized Trial
2005
Resistance gene capture
1999
Aminoglycosides: An Overview
2016
Antimicrobial resistance in gram-positive bacteria
2006
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
The microbiology of chronic osteomyelitis: Prevalence of resistance to common empirical anti-microbial regimens
2010
Intravenous Colistin for the Treatment of Multi-Drug Resistant, Gram-Negative Infection in the Pediatric Burn Population
2007
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
2006
Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)
2006
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Mechanisms of Resistance to Quinolones
2005
Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial
2007
Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban wastewater treatment plant
2007
The therapeutic potential of carbon monoxide
2010 Standout
Mechanism of Quinolone Action and Resistance
2014 Standout
Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)
2004
Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital
2004
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum
2006
Contemporary Management of Uncomplicated Urinary Tract Infections
2008
Resistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
2006
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
The New β-Lactamases
2005
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Two-Center Collaborative Evaluation of Performance of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of Gram-Negative Bacteria
2006
Activity of Levofloxacin and Ciprofloxacin in Combination with Cefepime, Ceftazidime, Imipenem, Piperacillin-Tazobactam and Amikacin against Different <i>Pseudomonas aeruginosa</i> Phenotypes and <i>Acinetobacter</i> spp.
2004
Prevalence and Characterization of Class I Integrons among Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Patients in Nanjing, China
2006
Fluorine in medicinal chemistry
2007 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Epidemiology of Rifampin ADP-Ribosyltransferase ( arr-2 ) and Metallo-β-Lactamase ( bla IMP-4 ) Gene Cassettes in Class 1 Integrons in Acinetobacter Strains Isolated from Blood Cultures in 1997 to 2000
2003
Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
2005
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
2002
Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center
2004
Carbapenemases: the Versatile β-Lactamases
2007 Standout
A carbon monoxide‐releasing molecule (CORM‐3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia
2008
Acquired Vancomycin Resistance in Clinically Relevant Pathogens
2008
Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel
2006
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
High prevalence of antimicrobial-resistant genes and integrons in Escherichia coli isolates from Black-headed Gulls in the Czech Republic
2007
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
2007
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Genetic Environment and Transcription of ampC in an Acinetobacter baumannii Clinical Isolate
2004
Antibacterial drug discovery: is it all downhill from here?
2004
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
2007
Three Decades of β-Lactamase Inhibitors
2010 Standout
Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial
2006
Genomics and the evolution of antibiotic resistance
2016
Colistin Methanesulfonate against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model
2007
Identification of Epidemic Strains of Acinetobacter baumannii by Integrase Gene PCR
2001
Food Animals and Antimicrobials: Impacts on Human Health
2011 Standout
In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
2004
Burn Wound Infections
2006 Standout
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Novel Insights about Class 2 Integrons from Experimental and Genomic Epidemiology
2009
Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004
2004
Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China
2003
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Pathogenicity of Enterococci
2019
Integron-Associated Antibiotic Resistance and Phylogenetic Grouping of Escherichia coli Isolates from Healthy Subjects Free of Recent Antibiotic Exposure
2005
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women
2002
The Evolution of Class 1 Integrons and the Rise of Antibiotic Resistance
2008
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Antibiotic Resistance Genes as Emerging Contaminants: Studies in Northern Colorado
2006 Standout
Enterobacteriaceae Bloodstream Infections: Presence of Integrons, Risk Factors, and Outcome
2007
Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries
2018
Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa
2007
Works of Mark E. Jones being referenced
Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
2004
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds
1998
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States
2002
Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy
2004
Towards better surveillance of bacterial antibiotic resistance
1999
Class I integrons: prevalence and impact on antibiotic susceptibility in 278 consecutive unrelated Gram-negative blood isolates
1999
Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999
2001
Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001
2003
Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002
2004
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001
2003
Comparison of Four Antimicrobial Susceptibility Testing Methods To Determine the In Vitro Activities of Piperacillin and Piperacillin-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa
2003
In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
2003
Trends in Antimicrobial Susceptibilities among Enterobacteriaceae Isolated from Hospitalized Patients in the United States from 1998 to 2001
2003